No Data
Here's Why Insigma Technology (SHSE:600797) Can Afford Some Debt
Insigma Technology's Joint Stock Company Completes Hong Kong Listing
Insigma Technology (600797.SH): Jointly invested company Jiuyuan Genes plans to list on the main board of the Hong Kong Stock Exchange.
On November 20, Gelonhui reported that insigma technology (600797.SH) announced that its wholly-owned subsidiary, Zhejiang Insigma Technology Venture Capital Co., Ltd. (referred to as "Insigma Venture Capital"),'s participating company Hangzhou Jiuyuan Gene Engineering Co., Ltd. (referred to as "Jiuyuan Gene") disclosed its prospectus on the Hong Kong Stock Exchange website on November 20, 2024, planning a global offering. Among them, the Hong Kong public offering consists of 4,540,000 H shares (subject to reallocation), and the international offering consists of 40,858,800 H shares (subject to reallocation and may be adjusted based on the exercise of the over-allotment option), with an offer price.
insigma technology (600797.SH): The holding subsidiary is the general agent of Moore Thread in Zhejiang Province.
On November 15th, Gelonghui reported that insigma technology (600797.SH) stated on the interactive platform that its holding subsidiary, Zhejiang Wangxin Turing Electronics Co., Ltd., is the general agent for Moore Threads in Zhejiang Province.
Insigma Technology's (SHSE:600797) Weak Earnings May Only Reveal A Part Of The Whole Picture
Zhejiang University Wangxin Technology Co., Ltd. Report for the Third Quarter of 2024
There's No Escaping Insigma Technology Co., Ltd.'s (SHSE:600797) Muted Revenues Despite A 25% Share Price Rise
